Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × Nivolumab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma 15 Mesothelioma, Malignant 14 Solid Tumor 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Advanced Solid Tumors 6 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Solid Tumors 4 Advanced Solid Tumor 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Merkel Cell 3 Advanced or Metastatic Solid Tumors 3 Turcot syndrome 2 Stomach Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Wilms Tumor 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1

Interventions

pembrolizumab 6 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 niraparib 1 neotil 1 necitumumab 1 leronlimab 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Yoga 1 Watchful Waiting 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡